Shares of Sumitomo Pharma Co., Ltd. (OTCMKTS:DNPUF – Get Free Report) traded down 10.7% during trading on Tuesday . The company traded as low as $8.4050 and last traded at $8.4050. 350 shares changed hands during trading, a decline of 75% from the average daily volume of 1,383 shares. The stock had previously closed at $9.41.
Sumitomo Pharma Price Performance
The stock’s fifty day simple moving average is $9.70 and its 200-day simple moving average is $12.24.
About Sumitomo Pharma
Sumitomo Pharma Co, Ltd., trading OTC under the ticker DNPUF, is a global pharmaceutical company headquartered in Osaka, Japan. It engages in the research, development, manufacturing and marketing of prescription medicines. As part of the broader Sumitomo Group, the company applies integrated drug discovery platforms and collaborative partnerships to bring innovative therapies to market.
The company’s portfolio encompasses central nervous system disorders, oncology, immunology and regenerative medicine.
See Also
- Five stocks we like better than Sumitomo Pharma
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Receive News & Ratings for Sumitomo Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sumitomo Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
